P ≤ 0.05 was considered significant, and P ≤ 0.01 was considered highly significant.
← all excerpts
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease.
1
—
—
P ≤ 0.05 was considered significant, and P ≤ 0.01 was considered highly significant.